Compounds > (3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid

(3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid and Hepatitis--Viral--Human

(3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid has been researched along with Hepatitis--Viral--Human* in 1 studies

Other Studies

1 other study(ies) available for (3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid and Hepatitis--Viral--Human

Article	Year
Statin toxicity: a situation that mimics viral hepatitis. International journal of clinical pharmacology and therapeutics, 2005, Volume: 43, Issue:11 A case is presented involving a female patient who experienced rhabdomyolysis following high-dose therapy with a statin. Acute renal failure was a complicating factor necessitating the use of hemodialysis. The patient recovered fully within about 6 weeks. Topics: Acute Kidney Injury; Adult; Anticholesteremic Agents; Fatty Acids, Monounsaturated; Female; Fluvastatin; Hepatitis, Viral, Human; Humans; Indoles; Rhabdomyolysis; Simvastatin	2005

Article

Year

Statin toxicity: a situation that mimics viral hepatitis.

International journal of clinical pharmacology and therapeutics, 2005, Volume: 43, Issue:11

A case is presented involving a female patient who experienced rhabdomyolysis following high-dose therapy with a statin. Acute renal failure was a complicating factor necessitating the use of hemodialysis. The patient recovered fully within about 6 weeks.

Topics: Acute Kidney Injury; Adult; Anticholesteremic Agents; Fatty Acids, Monounsaturated; Female; Fluvastatin; Hepatitis, Viral, Human; Humans; Indoles; Rhabdomyolysis; Simvastatin

2005